Evaluation of pathways for progression of heterogeneous breast tumors
- PMID: 15530488
- DOI: 10.1016/j.jtbi.2004.08.002
Evaluation of pathways for progression of heterogeneous breast tumors
Abstract
To better understand the progression of heterogeneous breast cancers, four models of progession pathways have been evaluated. The models describe the progression through the grades of ductal carcinoma in situ (DCIS) 1, 2, and 3, and through the grades of invasive ductal carcinoma (IDC) 1, 2, and 3. The first three pathways, termed linear, nonlinear, and branched, describe DCIS as a progenitor of IDC, and grades of DCIS progressing into grades of IDC. The fourth pathway, termed parallel, describes DCIS and IDC as diverging from a common progenitor and progressing through grades in parallel. The best transition rates for the linear, nonlinear, and branched pathways were sought using a random search in combination with a directed search based on the Nelder-Mead simplex method. Parameter values for the parallel pathway were determined with heuristic graphs. Results of computer simulation were compared with clinically observed frequencies of grades of DCIS and grades of IDC that were reported to occur together in heterogeneous tumors. Each of the four pathways could simulate frequencies that resembled, to varying degrees, the clinical observations. The parallel pathway produced the best correspondence with clinical observations. These results quantify the traditional descriptions in which grades of DCIS are the progenitors of grades of IDC. The results also raise the alternative possibility that, in some tumors with both components, DCIS and IDC may have diverged from a common progenitor.
Similar articles
-
Progression of heterogeneous breast tumors.J Theor Biol. 2001 May 7;210(1):107-19. doi: 10.1006/jtbi.2001.2302. J Theor Biol. 2001. PMID: 11343435
-
Evidence that molecular changes in cells occur before morphological alterations during the progression of breast ductal carcinoma.Breast Cancer Res. 2008;10(5):R87. doi: 10.1186/bcr2157. Epub 2008 Oct 17. Breast Cancer Res. 2008. PMID: 18928525 Free PMC article.
-
Alterations of estrogen receptors, progesterone receptors and c-erbB2 oncogene protein expression in ductal carcinomas of the breast.Cell Biol Int. 2008 Jun;32(6):698-707. doi: 10.1016/j.cellbi.2008.01.007. Epub 2008 Jan 25. Cell Biol Int. 2008. PMID: 18296077
-
Biology of ductal carcinoma in situ classification based on biologic potential.Am J Clin Oncol. 2006 Jun;29(3):305-10. doi: 10.1097/01.coc.0000198740.33617.2f. Am J Clin Oncol. 2006. PMID: 16755185 Review.
-
The molecular journey from ductal carcinoma in situ to invasive breast cancer.Cancer. 2008 May 15;112(10):2130-42. doi: 10.1002/cncr.23430. Cancer. 2008. PMID: 18383519 Review.
Cited by
-
Normal tissue architecture determines the evolutionary course of cancer.Nat Commun. 2021 Apr 6;12(1):2060. doi: 10.1038/s41467-021-22123-1. Nat Commun. 2021. PMID: 33824323 Free PMC article.
-
Evolution of cooperation among tumor cells.Proc Natl Acad Sci U S A. 2006 Sep 5;103(36):13474-9. doi: 10.1073/pnas.0606053103. Epub 2006 Aug 28. Proc Natl Acad Sci U S A. 2006. PMID: 16938860 Free PMC article. Review.
-
Mammary carcinoma behavior is programmed in the precancer stem cell.Breast Cancer Res. 2008;10(3):R50. doi: 10.1186/bcr2104. Epub 2008 Jun 3. Breast Cancer Res. 2008. PMID: 18522749 Free PMC article.
-
[Preparation of two types p53 recombinant adenovirus and quantitative exogenous expression of green fluorescence protein by flow cytometry].Zhongguo Fei Ai Za Zhi. 2010 May;13(5):470-6. doi: 10.3779/j.issn.1009-3419.2010.05.17. Zhongguo Fei Ai Za Zhi. 2010. PMID: 20677644 Free PMC article. Chinese.
-
Patient-calibrated agent-based modelling of ductal carcinoma in situ (DCIS): from microscopic measurements to macroscopic predictions of clinical progression.J Theor Biol. 2012 May 21;301:122-40. doi: 10.1016/j.jtbi.2012.02.002. Epub 2012 Feb 9. J Theor Biol. 2012. PMID: 22342935 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical